Theodore Lamson
Director/Board Member at Eximis Surgical, Inc.
Profile
Theodore C.
Lamson is the founder of NeoTract, Inc. which was founded in 2004.
He held the title of President & Chief Executive Officer from 2004 to 2010.
Currently, he is a Director at Palette Life Sciences AB and an Independent Director at Eximis Surgical, Inc. In the past, he worked as Vice President-Advanced Technologies at Medtronic, Inc., Manager-Research & Development at Pfizer Inc., and Vice President-Research & Development at TransVascular, Inc. Dr. Lamson received his graduate and doctorate degrees from The Pennsylvania State University and his undergraduate degree from Rensselaer Polytechnic Institute.
Theodore Lamson active positions
| Companies | Position | Start |
|---|---|---|
Eximis Surgical, Inc.
 Eximis Surgical, Inc. Medical SpecialtiesHealth Technology Eximis Surgical, Inc. develops and manufactures surgical devices. It offers XCor, a specimen removal device that reduce surgery times and risks associated with traditional tissue removal methods. The company was founded by Donna Ford-Serbu, Kristin D. Johnson, William Gregg, and Dirk Johnson on June 5, 2014 and is headquartered in Louisville, CO. | Director/Board Member | - |
Palette Life Sciences AB
 Palette Life Sciences AB Medical SpecialtiesHealth Technology Palette Life Sciences AB operates as a pharmaceutical company. It specializes in developing products for local pain relief in obstetrics and gynecology. The company was founded by Berith Karlsson Tingåker, Gunvor Ekman-Ordeberg, Arne Folke Brodin and Lars Irestedt in 2009 and is headquartered in Solna, Sweden. | Director/Board Member | 2021-10-20 |
Former positions of Theodore Lamson
| Companies | Position | End |
|---|---|---|
Medtronic, Inc.
 Medtronic, Inc. Medical SpecialtiesHealth Technology Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN. | Corporate Officer/Principal | - |
TransVascular, Inc.
 TransVascular, Inc. Medical SpecialtiesHealth Technology Transvascular (TVI) is a development stage medical device company that is definig a new class of intervention for the treatment of vascular diseases and other disorders. Unlike conventional therapies that are limited to treatment within blood vessels, the company's novel therapeutic approach extends beyond the vessel boundaries | Chief Tech/Sci/R&D Officer | - |
| PFIZER, INC. | Chief Tech/Sci/R&D Officer | - |
NeoTract, Inc.
 NeoTract, Inc. BiotechnologyHealth Technology NeoTract, Inc. develops surgical devices for urological and gynecological disorders. It offers UroLift System, a minimally invasive device to treat lower urinary tract symptoms due to benign prostatic hyperplasia. The company was founded by Joshua Makower, Joseph Catanese, Theodore C. Lamson and Earl A. Bright II in 2004 and is headquartered in Pleasanton, CA. | Chief Executive Officer | 2010-07-11 |
Training of Theodore Lamson
| The Pennsylvania State University | Doctorate Degree |
| Rensselaer Polytechnic Institute | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| PFIZER, INC. | Health Technology |
| Private companies | 5 |
|---|---|
Medtronic, Inc.
Medtronic, Inc. Medical SpecialtiesHealth Technology Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN. | Health Technology |
NeoTract, Inc.
NeoTract, Inc. BiotechnologyHealth Technology NeoTract, Inc. develops surgical devices for urological and gynecological disorders. It offers UroLift System, a minimally invasive device to treat lower urinary tract symptoms due to benign prostatic hyperplasia. The company was founded by Joshua Makower, Joseph Catanese, Theodore C. Lamson and Earl A. Bright II in 2004 and is headquartered in Pleasanton, CA. | Health Technology |
TransVascular, Inc.
TransVascular, Inc. Medical SpecialtiesHealth Technology Transvascular (TVI) is a development stage medical device company that is definig a new class of intervention for the treatment of vascular diseases and other disorders. Unlike conventional therapies that are limited to treatment within blood vessels, the company's novel therapeutic approach extends beyond the vessel boundaries | Health Technology |
Palette Life Sciences AB
Palette Life Sciences AB Medical SpecialtiesHealth Technology Palette Life Sciences AB operates as a pharmaceutical company. It specializes in developing products for local pain relief in obstetrics and gynecology. The company was founded by Berith Karlsson Tingåker, Gunvor Ekman-Ordeberg, Arne Folke Brodin and Lars Irestedt in 2009 and is headquartered in Solna, Sweden. | Health Technology |
Eximis Surgical, Inc.
Eximis Surgical, Inc. Medical SpecialtiesHealth Technology Eximis Surgical, Inc. develops and manufactures surgical devices. It offers XCor, a specimen removal device that reduce surgery times and risks associated with traditional tissue removal methods. The company was founded by Donna Ford-Serbu, Kristin D. Johnson, William Gregg, and Dirk Johnson on June 5, 2014 and is headquartered in Louisville, CO. | Health Technology |
- Stock Market
- Insiders
- Theodore Lamson
